WHTCF (WELL Health Technologies) Cyclically Adjusted Revenue per Share: $1.53 (As of Mar. 2026)


WHTCF WELL Health Technologies Corp WHTCF
76 GF Score
Price $2.94
GF Value $5.13
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is WELL Health Technologies Cyclically Adjusted Revenue per Share?

WELL Health Technologies WHTCF +0.68% 76 Cyclically Adjusted Revenue per Share is $1.53 as of Mar. 2026. GuruFocus rates WHTCF with a GF Score™ of 76/100 and a GF Value™ of $5.13 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

WELL Health Technologies's adjusted revenue per share for the three months ended in Mar. 2026 was $1.053. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $1.53 for the trailing ten years ended in Mar. 2026.

During the past 12 months, WELL Health Technologies's average Cyclically Adjusted Revenue Growth Rate was 29.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 33.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of WELL Health Technologies was 48.10% per year. The lowest was 33.10% per year. And the median was 40.60% per year.

As of today (2026-07-04), WELL Health Technologies's current stock price is $2.94. WELL Health Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $1.53. WELL Health Technologies's Cyclically Adjusted PS Ratio of today is 1.92.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of WELL Health Technologies was 33.46. The lowest was 1.75. And the median was 3.71.


WELL Health Technologies  (OTCPK:WHTCF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

WELL Health Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.94/1.53
=1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of WELL Health Technologies was 33.46. The lowest was 1.75. And the median was 3.71.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


WELL Health Technologies Cyclically Adjusted Revenue per Share Related Terms


WELL Health Technologies Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for WELL Health Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WELL Health Technologies Cyclically Adjusted Revenue per Share Chart

WELL Health Technologies Annual Data
Trend Oct16 Oct17 Oct18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.63 0.93 1.11 1.49

WELL Health Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 1.31 1.37 1.49 1.53

WHTCF vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, WELL Health Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WELL Health Technologies Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WELL Health Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where WELL Health Technologies's Cyclically Adjusted PS Ratio falls into.


WHTCF
76GF Score
WELL Health Technologies Corp WHTCF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WELL Health Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, WELL Health Technologies's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.053/132.2600*132.2600
=1.053

Current CPI (Mar. 2026) = 132.2600.

WELL Health Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201604 0.005 101.370 0.007
201607 0.008 101.844 0.010
201610 0.006 102.002 0.008
201701 0.006 102.318 0.008
201704 0.000 103.029 0.000
201707 0.000 103.029 0.000
201710 0.000 103.424 0.000
201801 0.002 104.056 0.003
201804 0.027 105.320 0.034
201807 0.020 106.110 0.025
201810 0.018 105.952 0.022
201903 0.064 106.979 0.079
201906 0.059 107.690 0.072
201909 0.063 107.611 0.077
201912 0.067 107.769 0.082
202003 0.062 107.927 0.076
202006 0.062 108.401 0.076
202009 0.069 108.164 0.084
202012 0.086 108.559 0.105
202103 0.125 110.298 0.150
202106 0.269 111.720 0.318
202109 0.384 112.905 0.450
202112 0.434 113.774 0.505
202203 0.476 117.646 0.535
202206 0.507 120.806 0.555
202209 0.482 120.648 0.528
202212 0.502 120.964 0.549
202303 0.533 122.702 0.575
202306 0.546 124.203 0.581
202309 0.635 125.230 0.671
202312 0.717 125.072 0.758
202403 0.652 126.258 0.683
202406 0.650 127.522 0.674
202409 0.695 127.285 0.722
202412 0.646 127.364 0.671
202503 0.818 129.181 0.837
202506 1.014 129.892 1.032
202509 1.025 130.290 1.040
202512 1.090 130.370 1.106
202603 1.053 132.260 1.053

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $1.53 mean?
WELL Health Technologies (WHTCF) has a Cyclically Adjusted Revenue per Share of $1.53 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on WELL Health Technologies and its competitors.
Is WELL Health Technologies' Cyclically Adjusted Revenue per Share too high?
WELL Health Technologies' current Cyclically Adjusted Revenue per Share is $1.53. Overall, WELL Health Technologies has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' Cyclically Adjusted Revenue per Share compare to HCA and THC?
WELL Health Technologies' Cyclically Adjusted Revenue per Share of $1.53 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on WELL Health Technologies and its competitors. WELL Health Technologies's current Cyclically Adjusted Revenue per Share is $1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.13, compared to a current price of $2.94 — trading 42.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $1.53. WELL Health Technologies' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current Cyclically Adjusted Revenue per Share is $1.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WELL Health Technologies (WHTCF) Overvalued in 2026?

Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued. The current stock price of $2.94 is trading 42.7% below its estimated GF Value™ of $5.13. GuruFocus considers WELL Health Technologies to be Possible Value Trap.

Key valuation signals for WHTCF:

  • Cyclically Adjusted Revenue per Share: $1.53
  • GF Value™: $5.13 vs. price of $2.94 (42.7% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


WELL Health Technologies Business Description

Other Exchanges W7V:GermanyWELL:Canada
Address 375 Water Street, Suite 550, Vancouver, BC, CAN, V6B 5C6
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
76GF Score

Get the complete analysis for WHTCF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$5.13
GF Value